IFIH1 and clinically amyopathic dermatomyositis: “FLAIR score,” including ferritin, LDH, semi-quantitative anti-MDA5 grade, HRCT imaging score, and RPILD/non-RPILD based on a large-scale Chinese single-center cohort (n = 207), was proposed to predict mortality in CADM-ILD (1).